A 19-year-old, non-smoker woman with a recent history of fever, nausea, vomiting, bloody diarrhea and loss of taste and smell was admitted to the Tor Vergata Hospital. A nasofaringeal swab resulted positive for SARS-CoV-2. At entry, she had a body temperature of 38 °C, pulse of 110 beats/min, and 99% oxygen saturation. She had severe anemia but no shortness of breath or chest pain. C-reactive protein, platelets, fibrinogen and [d]{.smallcaps}-dimer were elevated. A chest and abdominal CT scan showed no pneumonia but increased contrast enhancement in the ileum and colon. No further pathogen was evidenced. After 1 week treatment with hydroxychloroquine, all the symptoms/signs disappeared except the severe anemia, which required a blood transfusion, and the enhanced inflammatory markers. The subsequent nasofaringeal swabs were negative for SARS-CoV-2. At day 16, a small bowel ultrasonography revealed an increased bowel wall thickening of the whole colon associated with an increased blood flow vascularization (Limberg score 4) ([Fig. 1](#fig0001){ref-type="fig"} , panels A-B) and ileocolonscopy showed an extensive colitis with mucosal friability, spontaneous bleeding and tiny and large ulcerations ([Fig. 1](#fig0001){ref-type="fig"}, panels C-D). Hematoxylin and eosin staining of the colonic biopsy samples showed ulcerations, crypt architectural distortion, a diffuse and active inflammatory infiltrate with crypt abscesses ([Fig. 1](#fig0001){ref-type="fig"}, panels E-F). SARS-CoV2 RNA in colon/ileal and fecal samples was negative \[[@bib0001],[@bib0002]\]. A diagnosis of ulcerative colitis was made and treatment with oral beclomethasone dipropionate and MMX-mesalamine was started.Fig. 1Bowel ultrasonography (panels A--B), ileocolonoscopy (panels C--D) and histology (panels E--F) showing final diagnosis of inflammatory bowel disease.Fig 1

The clinical spectrum of SARS‐CoV‐2 ranges from asymptomatic or mild respiratory disease to pneumonia with respiratory distress syndrome and/or sepsis (Covid-19), which can result in a fatal outcome. Common symptoms are fever, cough, and shortness of breath, but gastrointestinal symptoms can occur in infected patients in line with the demonstration that SARS-CoV-2 RNA can be detected in feces and some of the infected patients remain positive in stools after becoming negative in respiratory samples [@bib0003]. Notably, the human intestine expresses constitutively high levels of angiotensin-converting enzyme 2 (ACE2) and the transmembrane serine protease, which are needed for SARS-CoV-2 to gain entry into the cells. Consistently, elevated levels of fecal calprotectin have been documented in Covid19-infected patients with ongoing diarrhea even in the absence of fecal SARS-CoV-2 RNA [@bib0004]. Overall these findings suggest that SARS-CoV-2 infection can instigate an acute intestinal inflammation, which under specific circumstances (e.g. genetic susceptibility, exposure to environmental factors), can eventually evolve towards a chronic inflammatory disorder or potentially deteriorates the course of IBD [@bib0005]. The persistence of severe anemia and increased levels of inflammatory markers together with the marked mucosal inflammation, after clearance of the SARS-CoV-2, strongly support such a hypothesis.
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